Cost-effectiveness analysis of exemestane versus chemotherapy in post-menopausal hormonal responsive advanced breast cancer patients

被引：0
|
作者：
Sripan, P. [1 ]
Chitapanarux, I. [2 ]
Sruamsiri, R. [3 ]
Klunklin, P. [2 ]
机构：
[1] Chiang Mai Univ, Northern Thai Res Ctr Radiat Oncol, Fac Med, Chiang Mai, Thailand
[2] Chiang Mai Univ, Div Radiat Oncol, Dept Radiol, Fac Med, Chiang Mai, Thailand
[3] Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients
    Xie, Yibo
    Guo, Beibei
    Zhang, Rui
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2020, 18 (01)
  • [22] Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients
    Yibo Xie
    Beibei Guo
    Rui Zhang
    Cost Effectiveness and Resource Allocation, 18
  • [23] Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer
    Benedict, A
    Brown, RE
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (11) : 1789 - 1801
  • [24] Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
    Vakaramoko Diaby
    Georges Adunlin
    Simon B. Zeichner
    Kiran Avancha
    Gilberto Lopes
    Stefan Gluck
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2014, 147 : 433 - 441
  • [25] COST-EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES IN THE UNITED STATES FOR POST-MENOPAUSAL OSTEOPOROSIS (PMO)
    Parthan, A.
    Deflin, M. M.
    Yurgin, N.
    Huang, J.
    Taylor, D. C.
    VALUE IN HEALTH, 2012, 15 (04) : A38 - A38
  • [26] Pembrolizumab alone or in combination with chemotherapy versus chemotherapy for advanced gastric cancer: A cost-effectiveness analysis
    Lang, Yitian
    Lin, Yan
    Li, Dan
    Liu, Jiyong
    Liu, Xiaoyan
    CANCER MEDICINE, 2023, 12 (18): : 18447 - 18459
  • [27] Using estrogen to reduce serum cholesterol in post-menopausal women: A cost-effectiveness analysis
    Wemer, RM
    Mushlin, AI
    MEDICAL DECISION MAKING, 1998, 18 (04) : 463 - 463
  • [28] Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer
    Claessens, Anouk K. M.
    Busschbach, Jan J. V.
    Ramaekers, Bram L. T.
    Erdkamp, Frans L. G.
    Bouma, Jeanette M.
    van Leeuwen-Stok, A. Elise
    Tjan-Heijnen, Vivianne C. G.
    Bos, Monique E. M. M.
    ACTA ONCOLOGICA, 2022, 61 (05) : 619 - 624
  • [29] Cost-Effectiveness Analysis of Advanced Radiotherapy Techniques for Breast Cancer Patients
    Xie, Y.
    Zhang, R.
    Guo, B.
    MEDICAL PHYSICS, 2020, 47 (06) : E733 - E733
  • [30] MANAGEMENT OF ADVANCED BREAST-CANCER IN POST-MENOPAUSAL WOMEN - A COMPARATIVE TRIAL OF HORMONAL-THERAPY, CHEMOTHERAPY, AND A COMBINATION OF BOTH
    CLAVEL, B
    CAPPELAERE, JP
    GUERIN, J
    KLEIN, T
    POMMATAU, E
    BERLIE, J
    SEMAINE DES HOPITAUX, 1982, 58 (34): : 1919 - 1923
12345